Healthcare provider profile · identity verified

William G Stueve, MD

Family Practice · INDEPENDENCE, MO · NPI 1225016462

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	407	128
Rosuvastatin Calcium	Rosuvastatin Calcium	378	107
Amlodipine Besylate	Amlodipine Besylate	276	79
Levothyroxine Sodium	Levothyroxine Sodium	259	79
Lisinopril	Lisinopril	240	75
Losartan Potassium	Losartan Potassium	191	66
Albuterol Sulfate Hfa	Albuterol Sulfate	154	49
Gabapentin	Gabapentin	140	47
Metoprolol Succinate	Metoprolol Succinate	132	42
Omeprazole	Omeprazole	129	43
Carvedilol	Carvedilol	122	33
Pantoprazole Sodium	Pantoprazole Sodium	107	34
Metformin Hcl	Metformin Hcl	103	39
Tramadol Hcl	Tramadol Hcl	99	23
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	97	33
Jardiance	Empagliflozin	92	26
Escitalopram Oxalate	Escitalopram Oxalate	87	24
Alendronate Sodium	Alendronate Sodium	80	27
Famotidine	Famotidine	79	25
Potassium Chloride	Potassium Chloride	78	25
Hydrochlorothiazide	Hydrochlorothiazide	75	23
Metformin Hcl Er	Metformin Hcl	72	24
Tamsulosin Hcl	Tamsulosin Hcl	70	26
Furosemide	Furosemide	69	20
Prednisone	Prednisone	69	51
Pregabalin	Pregabalin	67	12
Sertraline Hcl	Sertraline Hcl	65	22
Trazodone Hcl	Trazodone Hcl	64	20
Montelukast Sodium	Montelukast Sodium	63	19
Simvastatin	Simvastatin	59	19
Mirtazapine	Mirtazapine	58	23
Spironolactone	Spironolactone	58	21
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	56	56
Fluticasone Propionate	Fluticasone Propionate	56	20
Eliquis	Apixaban	53	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	53	19
Metoprolol Tartrate	Metoprolol Tartrate	46	16
Clopidogrel	Clopidogrel Bisulfate	45	13
Meloxicam	Meloxicam	44	14
Duloxetine Hcl	Duloxetine Hcl	43	16
Allopurinol	Allopurinol	41	16
Fluoxetine Hcl	Fluoxetine Hcl	41	12
Triamcinolone Acetonide	Triamcinolone Acetonide	41	18
Trulicity	Dulaglutide	40	13
Chlorthalidone	Chlorthalidone	38	12
Baclofen	Baclofen	36	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	36	suppressed
Nystatin	Nystatin	35	suppressed
Ozempic	Semaglutide	35	12
Finasteride	Finasteride	33	12
Ropinirole Hcl	Ropinirole Hcl	33	suppressed
Ezetimibe	Ezetimibe	31	13
Shingrix	Varicella-Zoster Ge/As01b/Pf	31	26
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	30	26
Tizanidine Hcl	Tizanidine Hcl	30	suppressed
Xarelto	Rivaroxaban	29	suppressed
Xultophy 100-3.6	Insulin Degludec/Liraglutide	28	suppressed
Alprazolam	Alprazolam	27	11
Novolog Flexpen	Insulin Aspart	27	suppressed
Telmisartan	Telmisartan	27	suppressed
Glipizide	Glipizide	26	suppressed
Celecoxib	Celecoxib	25	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Lovastatin	Lovastatin	23	suppressed
Oxycodone Hcl	Oxycodone Hcl	23	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Ipratropium Bromide	Ipratropium Bromide	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Atenolol	Atenolol	21	suppressed
Cephalexin	Cephalexin	21	15
Clonazepam	Clonazepam	21	suppressed
Fluocinonide	Fluocinonide	21	suppressed
Glimepiride	Glimepiride	21	suppressed
Irbesartan	Irbesartan	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	11
Pravastatin Sodium	Pravastatin Sodium	20	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	19	19
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Spiriva Handihaler	Tiotropium Bromide	18	suppressed
Tresiba Flextouch U-200	Insulin Degludec	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Cefdinir	Cefdinir	16	14
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Rybelsus	Semaglutide	16	suppressed
Torsemide	Torsemide	16	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Incruse Ellipta	Umeclidinium Bromide	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	13	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Sodium Chloride	0.9 % Sodium Chloride	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Estradiol	Estradiol	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Temazepam	Temazepam	12	suppressed
Topiramate	Topiramate	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Azithromycin	Azithromycin	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	11
Terazosin Hcl	Terazosin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error